FREDUN PHARMACEUTICALS
Back to All Ratios
|
FREDUN PHARMACEUTICALS Last 5 Year EBIT Margin History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| EBIT Margin(%) | 13.58 | 10.99 |
What is the latest EBIT Margin ratio of FREDUN PHARMACEUTICALS ?
| Year | EBIT Margin |
|---|---|
| Mar2026 | 13.58 |
| Mar2025 | 10.99 |
How is EBIT Margin of FREDUN PHARMACEUTICALS Trending?
| Years | EBIT Margin | % Change | |
|---|---|---|---|
| Mar2026 | 13.58 | 23.57 | |
| Mar2025 | 10.99 | - | |
Other Financial Ratios of FREDUN PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹2,332.4 Cr | 0.5% | -5.6% | 232.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 0.5% |
-5.6% |
232.1% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses